Cited by 112Stress Responses and CortisolTryptophan and brain disordersAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Maintenance of a positive outlook during acute stress protects against pro-inflammatory reactivity and future depressive symptoms

Open access
Aschbacher, K., Epel, E., Wolkowitz, O.M., Prather, A.A., Puterman, E., Dhabhar, F.S.·2012·Brain, Behavior, and Immunity

Abstract

Unlabelled Cognitive and affective responses to acute stress influence pro-inflammatory cytokine reactivity, and peripheral cytokines (particularly interleukin-1 beta (IL-1β)), can act on the brain to promote depressive symptoms. It is unknown whether acute stress-induced changes in positive affect and cognitions (POS) and pro-inflammatory reactivity predict future depressive symptoms. We examined acute stress responses among women, to determine prospective predictors of depressive symptoms.Hypotheses (1) Stress-induced decreases in POS will be associated with stress-related increases in circulating IL-1β. (2) Acute stress-induced decreases in POS and increases in IL-1β reactivity will predict increases in depressive symptoms 1 year later. Thirty-five post-menopausal women were exposed to acute stress with the Trier Social Stress Task (TSST) and provided blood samples under resting conditions and 30 min after the conclusion of the TSST, which were assayed for IL-1β. IL-1β reactivity was quantified as post minus pre-TSST. Failure to maintain POS was quantified as the decrease in POS during the TSST. Change in depressive symptoms from the study baseline to the following year was determined. Greater acute stress-induced declines in POS were significantly associated with increased IL-1β reactivity (p≤.02), which significantly predicted increases in depressive symptoms over the following year (p<.01), controlling for age, body mass index, chronic stress, antidepressant use and baseline depressive symptoms. IL-1β reactivity was a significant mediator of the relationship between POS decline and future increases in depressive symptoms (p=.04). Difficulty maintaining positivity under stress and heightened pro-inflammatory reactivity may be markers and/or mechanisms of risk for future increases in depressive symptoms.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbi.2011.10.010

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The greater the inflammatory response to a psychosocial stressor, the more probable the subject is to develop depression over the ensuing months.

    “the greater the inflammatory response to a psychosocial stressor, the more probable the subject is to develop depression over the ensuing months5.”

    From The role of inflammation in depression: from evolutionary imperative to modern treatment target (2016) · cites this paper as [5]

    The Results (Hypothesis 2; page not provided) report that greater IL-1β reactivity to acute stress was associated with greater increases in depressive symptoms one year later. The Methods (Inventory of Depressive Symptoms; page not provided) show that the outcome was a change in symptom score, not the probability of developing depression; the prospective sample was also limited to post-menopausal women. (LLM, conf=0.90)

    Experimental — accuracy not yet measured
  • Increases in circulating IL-1β predicted increases in depressive symptoms over the following year.

    “increases in circulating IL-1 β in turn predicted increases in depressive symptoms over the following year”
  • Greater difficulty in maintaining a positive cognitive-affective state during the TSST was associated with greater increases in circulating IL-1β.

    “greater difficulty in maintaining a positive cognitive-affective state during the TSST was associated with greater increases in circulating IL-1 β”
  • IL-1β reactivity to the TSST significantly mediated the relation between cognitive-affective responses to the TSST and future increases in depressive symptoms over the 1-year follow-up period.

    “IL-1 β reactivity to the TSST significantly mediated the relation between cognitive-affective responses to the TSST and future increases in depressive symptoms over the 1-year follow-up period”
  • Increases in IL-1β in response to TSST predicted the increase of depressive symptoms 1 year later.

    “increases in IL-1β in response to TSST predicted the increase of depressive symptoms 1 year later (Aschbacher et al., 2012).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Aschbacher, K., Epel, E., Wolkowitz, O. M., Prather, A. A., Puterman, E., & Dhabhar, F. S.
Affiliations
  • University of California, San Francisco (US)
  • Stanford Medicine (US)
Venue
Brain, Behavior, and Immunity
Publisher
Elsevier BV
Published
2012-02
Volume
26
Issue
2
Pages
346-352
ISSN
0889-1591 (ISSN-L)
OpenAlex
W2015010043
Cited by
112
References
48
Citations by year
2026: 2 · 2025: 7 · 2024: 6 · 2023: 9 · 2022: 8 · 2021: 11 · 2020: 6 · 2019: 16 · 2018: 12 · 2017: 6 · 2016: 11 · 2015: 3 · 2014: 7 · 2013: 5 · 2012: 2
FWCI
1.88
Type
journal article
Language
en
Open access
Locations
  • Brain Behavior and Immunity (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health
  • University of California, San Francisco
  • National Institute on Aging (R01AG030424)
  • National Heart, Lung, and Blood Institute (K23HL112955)
Topics
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords
acute stress, positive affect, IL-1β, inflammatory cytokines, depressive symptoms, Trier Social Stress Test, postmenopausal women, mediation
MeSH terms
Affect, Aged, Depression, Female, Humans, Inflammation, Middle Aged, Psychiatric Status Rating Scales, Stress, Psychological, Time Factors, Interleukin-6, Interleukin-1beta

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review